Replies to post #15429 on Marker Therapeutics Inc (MRKR)

[lasers]

$TPIV 80 person study will be to compare TPIV200 vs Chemotherapy Drug: Cyclophosphamide

https://clinicaltrials.gov/ct2/show/study/NCT02593227#contacts

Sarah Cannon Research Institute Active, Nashville, Tennessee

http://sarahcannon.com/


Cyclophosphamide:
http://druginfo.nlm.nih.gov/drugportal/rn/6055-19-2